Dr. Moopen’s Family increases 4% stake for Rs. 460 crore in Aster DM Healthcare
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
Natural Capsules Limited's shareholding will be reduced to 89.99%
Agasta Software is engaged in research, development and commercialization of medical devices
Qure.ai is scaling-up the integration of its AI-powered chest x-ray interpretation tool that can benefit early and easy detection of lung diseases including lung cancer.
The company has also been named among global sustainability leaders for the 7th year in a row in the Dow Jones Sustainability Index in the Emerging Markets category
Operating EBITDA grew by 82.7 % to Rs. 14.4 crore, EBITDA margin at 23.9%, and Profit After Tax (PAT) grew by 47.1% to Rs. 7.8 crore
Products offered on a not-for-profit basis to the 45 lower-income countries now include the full portfolio for which Pfizer has global rights.
OrbiMed's exercise of warrant conversion will further strengthen the company's net cash position to over Rs.650 crores.
Subscribe To Our Newsletter & Stay Updated